OrderlyMeds operates a telemedicine platform focused on medical weight loss treatment, serving over 40,000 members across all 50 U.S. states. Founded in 2023, the company delivers personalized, evidence-based treatment programs through remote consultations with licensed healthcare professionals, supported by direct-to-home medication delivery.
The platform integrates clinical oversight with supplementary resources in nutrition, fitness, and mental health support. Treatment plans are individually tailored and designed for remote management, removing traditional barriers such as insurance requirements and in-office visit logistics. Virtual consultations and prescription fulfillment operate nationwide, making care accessible across the country.
OrderlyMeds operates as a fully distributed, remote organization. The company's technical infrastructure spans telemedicine systems, patient management, pharmacy operations, and GLP-1 medication delivery. The service model emphasizes transparent pricing and straightforward patient onboarding.
